Sodium Pertechnetate
Sodium pertechnetate is an inorganic technetium salt used as a general-purpose radiopharmaceutical precursor and diagnostic imaging agent for thyroid scintigraphy, Meckel's diverticulum scanning, and radionuclide ventriculography in prostate cancer and rheumatoid arthritis assessment. As the pertechnetate anion (TcO4-), it is a chemical analog of iodide and is concentrated by the thyroid gland and gastric mucosa via the sodium-iodide symporter. It is the primary precursor for labeling other technetium-99m radiopharmaceuticals.
Molecular Weight
183.8940 g/mol
TPSA
74.30 Ų
Therapeutic Areas
Mechanism of Action
Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.
SMILES
[O-][Tc](=O)(=O)=O.[Na+]
InChI
InChI=1S/Na.4O.Tc/q+1;;;;-1;
Molecular Formula
NaO4Tc
HBD / HBA
- / 4
Rotatable Bonds
0
Heavy Atoms
6
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
Frequently Asked Questions
Sodium pertechnetate is an inorganic technetium salt used as a general-purpose radiopharmaceutical precursor and diagnostic imaging agent for thyroid scintigraphy, Meckel's diverticulum scanning, and radionuclide ventriculography in prostate cancer and rheumatoid arthritis assessment. As the pertechnetate anion (TcO4-), it is a chemical analog of iodide and is concentrated by the thyroid gland and gastric mucosa via the sodium-iodide symporter. It is the primary precursor for labeling other technetium-99m radiopharmaceuticals.
Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.
Yes, Sodium Pertechnetate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2110571. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 74086836. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="sodium-pertechnetate"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/sodium-pertechnetate/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/sodium-pertechnetate/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/sodium-pertechnetate/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="sodium-pertechnetate"></drugfyi-drug>